T1	intervention 30 51	Calendula officinalis
T2	control 66 75	trolamine
T3	condition 98 114	acute dermatitis
T4	location 452 458	France
T5	duration 592 623	Between July 1999 and June 2001
T6	No-of-participants 625 628	254
T7	control-participants 797 800	128
T8	intervention-participants 825 828	126
T9	outcome-Measure 914 965	occurrence of acute dermatitis of grade 2 or higher
T10	outcome-Measure 1101 1119	occurrence of pain
T11	outcome-Measure 1125 1155	quantity of topical agent used
T12	outcome-Measure 1161 1181	patient satisfaction
T13	outcome 1187 1238	occurrence of acute dermatitis of grade 2 or higher
T14	intervention-value 1264 1267	41%
T15	control-value 1270 1273	63%
T16	outcome 1421 1465	significantly reduced radiation-induced pain
T17	outcome 1527 1565	self-assessed satisfaction was greater
T18	eligibility 629 736	patients who had been operated on for breast cancer and who were to receive postoperative radiation therapy
